Intratympanic Methylprednisolone Injection as First Line Therapy for Idiopathic Sudden Sensorineural Hearing Loss
Introduction Steroid therapy is considered to be the gold standard for sudden sensorineural hearing loss (SSNHL). Delivering steroids by intratympanic injection is more efficient than systemic injections with minimum or no side effects. The present study was aimed to evaluate the efficacy and saf...
Main Authors: | Mukul Patar, Rupanjita Sangma |
---|---|
Format: | Article |
Language: | English |
Published: |
The Association of Otolaryngologists of India, West Bengal
2017-08-01
|
Series: | Bengal Journal of Otolaryngology and Head Neck Surgery |
Subjects: | |
Online Access: | https://bjohns.in/journal3/index.php/bjohns/article/view/115 |
Similar Items
-
Intratympanic Methylprednisolone Injection as First Line Therapy for Idiopathic Sudden Sensorineural Hearing Loss
by: Mukul Patar, et al.
Published: (2017-08-01) -
Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss
by: Nezamoddin Berjis, et al.
Published: (2016-01-01) -
Intratympanic injection of dexamethasone for treatment of tinnitus in patients with sudden sensorineural hearing loss
by: Tadao Yoshida, et al.
Published: (2012-01-01) -
Effect of Intratympanic Dexamethasone in Idiopathic Sudden Sensorineural Hearing Loss
by: Rabi Hembrom, et al.
Published: (2019-08-01) -
Effect of Intratympanic Dexamethasone in Idiopathic Sudden Sensorineural Hearing Loss
by: Rabi Hembrom, et al.
Published: (2019-08-01)